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CHAPTER I 
INTRODUCTION 
The relationship between infection and kidney disease~ has been 
recognized since the 17th century (11); in this century streptococcal 
infection has been clearly identified as the cause of membrana-proli-
ferative glomerulonephritis. Glomerulonephritis occurs 1-4 weeks after 
pharyngeal or pyodermic infection with group A streptococcal types: l~ 
4~ 12~ 25~ and 49 (11). Glomerulonephritis also occurs less commonly 
with type 8~ and has recently associated with types: 59 and 60 (4). 
Numerous workers have attempted to further the understanding of 
"naturally" occurring glomerulonephritis and glomerulonephritis induced 
experimentally in animals. Two general immunologic mechanisms have 
been suggested to be involved in the production of glomerulonephritis 
as a result of these studies. In the first~ the glomerular deposition 
of soluble antigen-antibody in complexes is thought to result in a 
subsequent inflammation response and resultant tissue damage (11, 25, 
29). The antigen involved may arise from either exogenous or endo-
genous source and may not necessarily be related to antigenic deter-
minants on the glomerular basement membrane (GBM). In the second, cir-
culating antibodies are thought to be elicited by sensitization either 
to exogenous antigen, or to endogenous antigen that is immunologically 
cross reactive with the critical renal antigens located in the GBM (11, 
46). Both of these mechanisms probably cause glomerular damage through 
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activation of the complement sequence which, in turn, is closely inter-
related with the coagulation process (8, 11). Evidence for the latter 
mechanism has been obtained by animal immunization with heterologous 
GBM (40, 45), homologous GBM (17, 32, 44), and autologous GBM (35). 
In man, it has been suggested that glomerular lesions may result 
from immunological damage due to antibodies induced by renal GBM anti-
gens (11). The role of streptococcal membrane antigens have been 
particularly stressed. Streptococcal membranes cross react with GBM 
and thus could produce antibody that complex the host's own basement 
membrane antigens (30). 
The fact that not all beta-hemolytic streptococcal infections are 
followed by nephritis has lead to the classification of streptococcal 
organisms into 2 groups, designated nephritic and non-nephritic strains 
{8). Nephritis may take place after either tonsillitis (pharyngitis} or 
pyoderma (8}. Table 1 describes the occurrence as reviewed by Wanna-
maker (11). Nephritis following either type of infection has a similar 
course and a generally favorable long term prognosis. 
Investigations of nephrotoxicity of renal tissues suggest that the 
nephrotoxic immunogenicity resides primarily in the GBM (34). The GBM 
is an extracellular homogenous layer approximately 0.2 ~ (adult human) 
in diameter located between endothelium and epithelial cells and around 
mesangeal cell (34}. The physiological importance of the GBM is that 
it is the only complete barrier between the plasma and its filtrate. 
It is also the primary site of a number of diseases associated with the 
kidney (11 ). The anatomical location of the glomerular basement mem-
brane is such that it can be isolated in pure form and thus can be 
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chemically and immunologically characterized. 
It has been shown that the nephrotoxicity induced by antisera 
directed against GBM or SCM is not species specific (3, 13). Antisera 
induced by human GBM antigens will cross react with certain SCM anti-
gens as well as other mammalian tissue antigens: kidney antigens of 
dog (39), mice (39), guinea pigs (39), rhesus monkey (27), human lungs 
(3}, human connective tissue (18}, human lymphocytes (40), and chim-
panzee lymphocytes (40}. Antisera directed against SCM antigens have 
been found to be immunologically reactive with numerous mammalian 
tissue antigens: human thymus (40), human skin epithelial cells (18}, 
kidney antigens of humans (11), dogs (39}, rats (39), guinea pigs (39), 
and rhesus monkeys (27). 
It has been suggested that similarity of response to two antigenic 
stimuli may suggest a common structure (39}. Thus, the above studies 
suggest a definite relationship of the antigenic determinants of human 
GBM to certain types (nephrotogenic} of group A- 13hemolytic strepto-
coccal cell membranes. Much work remains to be done in this area. 
To date, our _lab has presented substantial evidence to verify the 
immunologic relatedness of SCM and GBM. Techniques that we have uti-
lized to show cross reactivity of antisera di~ected against SCM and 
G&~ include immunodiffusion (4), indirect fluorescent antibody technique 
(5}, and passive hemagglutination (4). That this cross reactivity is 
reciprocal has been shown through heterologous absorption studies (4). 
Immunodiffusion studies were carried out by the double diffusion 
procedure using a random selection of available antisera. The number 
of positive precipitin lines vs. the total number tested were compared 
• 
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{4). Only those antisera producing positive fluorescense upon evalua-
tion of normal human kidney cortex produced any precipitin lines against 
any GBM antigen (5). 
In heterologous studies antisera were incubated with different 
fractions of GBM and SCM and then reacted with normal GBM (4). SCM 
preparations which were not treated with carbohydrases illustrated 
little antibody absorbing activity when compared to the anti-glomerular 
antisera. GBM or whole human glomeruli preparations completely absorb-
ed out all antibody activity. In reciprocal tests involving incubation 
of GBM preparations with anti-streptococcal antisera similar results 
were noted. The results of reciprocal absorption tests also indicate 
that cross reacting antigens on both GBM and SCM may be masked by 
carbohydrate units (4). 
Several publications have dealt with the chemical properties of 
the GBM of animals, particularly bovine GBM (42). Amino acid and 
carbohydrate analysis have been carried out on human and mouse GBM 
(19, 20, 22, 23). Carbohydrate analysis of cross-reactive peptides 
demonstrated that human glomerular basement membrane and the strepto-
coccal cell membrane were indeed glycoprotein of a similar nature (19, 
20). As yet little has been published concerning the SCM components 
{19, 20). Thus, a great deal of work remains to be done in the area 
of the primary structure of determinants located on the cell membranes 
of nephritogenic streptococci. 
The basement membrane has been indicated as closely related to 
collagen in composition (41). It is essentially a glycoprotein with 
a carbohydrate content of 9% (41, 42). Two distinct types of carbohy-
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drate units were observed in bovine GBM (41, 42). The first, a disac-
charide, appears to be linked by the hydrosyl group of hydroxylysine. 
The second, a heteropolysaccharide, seems to be linked by asparagine. 
The presence of a similar carbohydrate and amino acid content in humans 
and bovine GBM indicates a similarity of structure. Tables 2 and 3 
indicate the amino acid and carbohydrate analysis for human and mouse 
glomerular basement membrane determinations respectively. 
The total carbohydrate content of both human and mouse neonatal 
GBM was approximately 1.4% less than that found in the adult GBt1 (19). 
In particular,·the quantity of hexoses, sialic acid, fucose and hexose-
amines, were found to be less in neonates than in the adult mouse (19). 
The same results were obtained when human neonatal GBM was compared to 
adult GBM, with a single exception, i.e. the sialic acid content which 
was found to be surprisingly higher in the neonatal GBM. 
Hydroxylation of proline and lysine occurs with maturation as 
demonstrated by the combined proline and 1-hydroxyproline or lysine and 
hydroxylysine micromolar concentrations remaining constant in the adult 
and the neonate (19). The percent increase in carbohydrate {glucosyl-
galactosyl disaccharide) can be correlated to the hydrosylysine increase 
indicating that the changes in antigenicity may be attributed chemical 
changes occurrlngin the maturation of the animal's GBr~. 
The cross reactions which occur between SCM and GBM seem to depend 
to a great extent on protein epitopes. Nephrotoxic antibodies produced 
by immunization with whole human GBM or whole SCM have been observed to 
be primarily anti-protein determinant in nature (4, 5, 6, 19). 
The antigenicity of the human GBM has been found to increase after 
carbohydrate cleavage of the carbohydrate units with carbohydrases (5). 
Supernatants of anti-human GBM antisera, following reaction with non-
carbohydrase treated antigen, were shown to react with carbohydrase 
treated antigen. It has been suggested that some of the antigenic 
sites on the native glycoproteins are wholly or partially masked by 
carbohydrate units (6). Removal of carbohydrates may take place during 
the immune response of the host, allowing for the formation of anti-
bodies toward these areas. Sera from individuals infected with strep-
tococcal organisms have been shown to contain these carbohydrases (6). 
Supernatants obtained from antisera after reaction with native 
antigen still react with sialic acid-free antigen and with antigen from 
which other carbohydrates have been removed (36}. It appears that the 
protein, and especially the protein epitopes near carbohydrate attach-
ment points, are directly involved in these immunologic reactions (37). 
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Antisera to type 12, group A streptococcal cell membrane react 
with human kidney cortex, and after carbohydrase treatment this reacti-
vity was found to decrease as observed by immunofluorescence. Similar~, 
no enhancement of fluorescence after treatment of neonatal tissues with 
carbohydrase was observed. Neonatal tissue was generally not as reac-
tive as the adult with the defined antisera used in these experiments 
(4, 5, 6). 
Further evidence for the nephrotoxicity of glycoproteins is the 
discovery of a sialoglycoprotein of 50,000 daltons determined to be 
the nephrotoxic antigen _of GBM in Masugi nephritis (32). Also, studies 
on the rat GBM have shown that nephrotoxic antigens contain the 
following carbohydrates: galactose, mannose, sialic acid, glucos-
amine and galactosamine (17). 
When sodium lauryl sulfate solubilized SCM and trypsinized SCM 
are prepared and the gross amino acid content determined, there does 
not seem to be a direct relationship to GBM. However, the peptides 
that were observed to give consistent cross reactivity were those with 
the highest carbohydrate and asparagine content (19). Carbohydrates 
found in cross reactive fractions were rhamnose, ribose, glucose, 
galactose, glucosamine and galactosamine. No sialic acid was detected 
in the SCM. 
Freimer (12) also studied the chemical and immunologic properties 
of group A streptococci in the form of protoplasts and L-forms. 
Chemical analysis showed SCM to be 85% lipoprotein, 25% lipid, 71% 
protein, and 2% carbohydrate which was mostly glucose. 
Similarity of antigenic determinants or immunological cross reac-
tivity beb1een scr-1 and GBM may be important in the study of kidney 
transplant rejection phenomenon. It has been shown that immunization 
with certain bacterial species correlates well with accelerated or 
"white graft 11 rejection of skin grafts in guinea pigs (21). Some of 
the bacterial species that have been shown to .cause such effects are 
streptococcal groups A, B, C, D, E, G, H, L and 0; Staphylococcus 
aureus and Staphylococcus epidermidis. None of the numerous gram 
negative organisms which have been studied, gave similar results (11). 
Pretreatment of outbred guinea pigs with heat killed group A strepto-
coccal type 4, 5, 6, 11, 12, 14 and 19 produced a state of hypersensi-
tivity to skin allografts in the recipient that is indistinguishable 
7 
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from that induced by pretreatment with allogenic tissues (38). Passive 
immunization of male guinea pigs by intradermal injection of anti-SCM 
brings about a rejection that has been described as Arthus type (21). 
Antisera directed against group A SCM is cross reactive with cer-
tain HLA antigens found on human lymphocytes and a similar antigen 
located on the lymphocyte of chimpanzees (40). It has been suggested 
that histocompatibility antigens that cross react with group A SCM 
components may have a group like distribution (40). This group like 
distribution may play a significant role in host resistance to strep-
tococcal sequellae diseases. Absence of certain histocompatibility 
antigens which are similar to, or cross-reactive with group A SCM may 
actually correlate with the ability of the host to respond to infection. 
This could account for the 85-90% of the individuals that do not develop 
glomerulonephritis after infection with nephrotoxic strains. 
Host variation in reactivity with antisera directed against either 
GBM or SCM has been shown in several studies on passive nephritis 
induced by intraperitoneal injection of antisera (2, 24). Rapid 
exchange of protein between the ascitic pool and circulating plasma 
takes place in the rabbit and the mouse (31). Fluid from the peritoneal 
cavity enters the portal system, specifically the supradiaphragmatic 
vena cava (31). In dogs, whole erythrocytes are readily passed from 
the peritoneal cavity into the lymph spaces and eventually into the 
larger veins through the thoracic duct (31). 
Myers (33) produced rabbit antisera to an antigen rich in sodium 
hydroxide soluble murine basement membrane and reticulum fractions. 
Although no nephrotoxic effects were observed, these antisera, when 
injected into Swiss albino mice, fixed to the GBM and not elsewhere 
after 5 minutes, and remained fixed for 3 weeks (33). Deposition of 
material along the GBr•1 did not correlate with glomerular damage as 
reflected in proteinuria and cellular changes. 
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In a study of immune-complex glomerulonephritis in the monkey 
(Macaca irus), the greatest electron density was demonstrated in the 
epithelial cells and in those portions of the foot processes adjacent 
to the GBM (35). Similar deposits were occasionally observed in the 
mesangial matrix. Most of the antibody activity occurred in the IgM 
fraction by immunofluorescent microscopy. Fifty percent of the mon-
keys demonstrated both hypercellularity and focal GBM thickening by 
light microscopy. One monkey, who had no detectable immunoglobulin 
or complement deposits, also showed unexplained increase in cellularity, 
matrix and GBM thickening (35). 
It has been shown that nephritis can be induced in animals through 
injection of antisera and that these reactions are immunologically 
specific. Such studies can lead to a greater understanding of the 
relatedness of GBM and SCM and may eventually lead to elucidation of 
the structure of the GBM. 
The studies reported in this thesis were undertaken in order to 
evaluate the relative reactivity of antisera against protein or carbo-
hydrate determinants of either SCM or GBM. Those antisera found to 
react specifically with either carbohydrates or protein determinants 
were used to study the immunogenicity of the maturing mouse kidney GBM 
with respect to changes in carbohydrate or protein content. These 
same antisera were used in immunofluorescent studies in which removal 
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of carbohydrates was performed in an attempt to gain information about 
the possible arrangement of carbohydrates involved in the antigenicity 
of the GBM. 
CHAPTER II 
MATERIALS AND METHODS 
A. Antisera 
All antisera had been previously prepared in New Zealand white 
rabbits·and tested for antigenic specificity before use (5, 6, 21, 30). 
Anti-carbohydrate antisera were prepared against pronase digests of 
either SCM or GBM. The pronase digested material contained 30% carbo-
hydrate as compared to the normal tissue content of 5-10%. The pronase 
digested material was determined to have low molecular weight and was 
linked to carrier molecules to form immunogens. Five milligram quanti-
ties in l ml Freunds adjuvant were then used in the immunization of 
rabbits (4). Anti-protein antisera were directed against whole SCM, 
human GBM, or soluble fractions of these membranes (5, 6, 21, 30). 
Irrespective of their nature, the major response in animals has been 
found to be primarily anti-protein in nature. Again, 5 mg quantities 
were used to immunize rabbits. The basic regime was to obtain a pre-
immunization bleeding on day 0 and to immunize with 1 ml of complete 
Freunds adjuvant containing 2.5 mg antigen. One half the challenge was 
given ID on the back of the neck and the balance in the rear right foot 
pad. On day 14 a second dose was given (l ~] CFA) IM. The test bleed-
ings were made on day 21. If sufficient reactivity was present animals 
were exsanguinated for antiserum. Poor responders were given a third 
dose on day 22 and then exsanguinated on day 32. Table 2 further 
explains the character of the antisera and the origin of the immunogens. 
11 
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B. Kidneys 
Human kidneys were obtained from the morgues of Hines Veterans 
Hospital, Hines, Illinois or McGaw Hospital, Loyola University. Taken 
from bodies that were determined not to have kidney disease, the kid-
neys were normal in appearance both under gross inspection and under 
the light microscope. Of the four kidneys employed in these studies, 
three were adult and one was neonatal. Neonatal kidneys were consider-
ed to be those less than two months of age, while adult human kidneys 
were those over 25 years. Frozen kidney sections were evaluated for 
the number of glomeruli and for obvious glomerular abnormalities and 
none were observed. The kidneys were stored in -80°C for periods up 
to one year. 
Kidneys were also obtained from three strains of mice from the 
investigators own colony. The animals used in the study appeared to be 
free of disease. The strains studied were Swiss white, C5781, and C3H. 
Neonatal mice were less than 15 days. Adult mice were over 2 months of 
age. Kidneys were either used immediately or stored at -80°C for later 
use. 
C. Kidney Sections 
Kidney sections of both mouse and human origin \'Jere cut on a harris 
cryostat from the International Equipment Company of Needham, Massachu-
setts. Sections, 2 microns thick, were cut from 2-3 mm3 cubes of human 
kidney cortex or from half mouse kidneys embedded in O.C.T. compound 
(Ames, Co., Elkhart, Indiana) and frozen on dry ice. Sections were 
placed on glass slides, fixed in cold acetone at 4°C, and washed three 
/ 
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times for 10 minutes in 20 cc phosphate buffered saline (PBS) solution, 
pH 7.4. The slides were either used immediately in immunofluorescent 
antibody tests or were frozen and stored at -20°C for later use. Liver, 
lung and heart tissues for controls were processed in the same manner. 
D. Sheep anti-rabbit fluorescent conjugates 
Sheep anti-rabbit IgG was tested for specificity against rabbit 
IgG by immunoelectrophoresis and direct slide precipitation. Globulins 
were precipitated by adding 3.5 gm of sodium sulfate slowly to 25 ml of 
antiserum {12-15% saturation) under constant stirring at room tempera-
ture. The mixture was stirred for 2 hours and then centrifuged (Sorvall 
RC2) at 1800 rpm for 30 minutes at room temperature. After decanting 
the supernatant, the precipitate was dissolved in 25 ml of physiologic 
saline and the precipitation with sodium sulfate was repeated twice 
more. The precipitate obtained was dissolved in a volume of borate 
saline equal to one-half of the original serum volume. Dialysis of 
this material was carried out against a borate buffered solution, pH 
8.45, for 3-4 days at 4°C with daily changes of buffer, until the test 
for sulfate was negative {1% barium chloride precipitation). If a 
white precipitate formed, dialysis was continued for another 18 hours 
and the dialysate was tested in the same manner. After isolation of 
globulins had been completed the protein content was determined by the 
biuret procedure {46). Adjustment of the protein concentration to 1% 
was made with the addition of borate saline. The final adjustment of 
the pH to a range of 8.4~9.0 was made by careful addition of 0.1 ~ 
sodium hydroxide solution. The solution was chilled on an ice bath 
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and 0.05 mg fluorescein isothiocyanate per mg of globulin was added 
and stirred for one hour. The solution was left standing (with gentle 
stirring) overnight at 4°C. Excess fluorescein was removed from the 
mixture by dialysis for 24 hours versus BBS buffer and by passage over 
a Sephadex G25 column. All conjugates were protected from excess light. 
The resulting preparation was lyophilized and stored until use. The 
lyophilized conjugate was absorbed by the addition of 75 mg of Norite-A 
(charcoal) to 10 mg of conjugate in one ml of PBS and the mixture was 
stirred for one hour. After centrifugation (Sorval1-RC2) at 15,000 rpm 
for 10 minutes, the material was diluted 1:20 and 1:40 and tested 
against a known conjugate already in use in the laboratory. Further 
dilutions of the newly prepared conjugate were made to obtain dilutions 
which produced no background fluorescence and a good subjective reading 
of 3-4+ on the known 3-4+ control tissues. 
E. Immunofluorescent evaluation of kidney section 
Tissue section slides were incubated with specific antisera for 40 
minutes in a moist chamber at room temperature. The slides were washed 
in PBS 3 times, 10 minutes per wash, and then air dried. After incuba-
tion with fluorescein conjugated sheep anti-rabbit immunoglobulins, the 
s 1 ides \-Jere washed in PBS as described above. After air drying the 
slides were coverslipped with 90% glycerol-10% PBS. The sections were 
evaluated for glomerular fluorescent staining with a Leitz Wetzlar 
(E. Leitz, Inc., Rochleigh, New Jersey) fluorescent microscope. Controls 
included: tissue reacted with normal rabbit serum (NRS) or with fluo-
rescent conjugate; and, a known antiserum that gave 4+ reading with 
human GBr~ and a 2+ reading with mouse GB~1. Positive controls were 
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reviewed intermittently during fluorescent evaluations. All of the 
serum evaluation were done at least twice. Double blind test studies~ 
negative and positive control, were also done and results were similar 
to those found with known materials. Independent readings were made 
by at least two members of the laboratory. 
F. In vivo mouse evaluations 
Erythrocytes were obtained from Swiss white-mice by cardiac punc-
ture. Five-tenths of a milliliter of blood per mouse were obtained 
and immediately placed in Alsever•s solution.(2.0% glucose~ 80% sodium 
citrate~ 0.42% sodium chloride~ and 0.055% citric acid in water)~ The 
erythrocytes were centrifuged and the plasma removed. The red blood 
cells (RBC) were washed three times (0.89% saline) at room temperature. 
Anti-GBM or anti-SCM antisera that were found to give the greatest 
reactivity with the mouse or human GBM as determined by indirect immuno-
fluorescence were examined for macroscopic and microscopic agglutina-
tion of mouse RBC. All sera were found to agglutinate the cells~ and 
so were decomplemented by incubation in a 56°C water bath for30minutes, 
and then absorbed with 0.2 ml RBC per ml of sera for 10 minutes at 37°C 
to insure removal of possible heterologous antibodies. After centrifu-
gation, the absorbed sera were again examined·for macroscopic and micro-
scopic agglutination of mouse RBC. No further agglutination was 
observed. Tissue sections were evaluated with these sera and no change 
in fluorescent gradation was observed. 
These antisera were then injected either intraperitoneally (IP) or 
intravenously (IV) into adult mice and only IP into neonatal mice. 
Numerous experiments were performed to determine the least amount of 
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antiserum and the shortest optimum incubation time for maximum GBM fixa-
tion of antibody. Adult mice injected IP were found to give the great-
est fluorescence with 0.5 ml of antiserum at 6 hours incubation. When 
injected IV, 0.2 ml of antiserum gave equivalent fluorescence in 2 
hours time. IV injection of neonatal mice was not reproducible due to 
technical difficulties. After IP injection of neonatal mice, maximum 
fluorescence could be observed with 0.2 ml at 4 hours incubation. 
After incubation, animals were sacrificed and their kidneys were removed 
and prepared for light, electron microscopic and immunofluorescent eval-
uations. Livers, lungs and hearts were also removed and prepared for 
immunofluorescent evaluation. 
1. In vivo e-valuation of adult mice of three species: Swiss white, C3H, 
and C57Bl. 
Swiss white adult mice were injected both IP and IV \'lith selected 
sera as described above. The animals were sacrificed and the kidneys 
were prepared as described above. Tissue sections were evaluated for 
fluorescence and for the form of deposition on the GBM (linear or granu-
lar). C3H and C57Bl mice were injected only IV and evaluated in the 
manner of the Swiss white mice. 
2. In vivo evaluation of neonatal mice of three species: Swiss white, 
C3H, and C57Bl. 
Neonatal mice were injected IP and sacrificed as described above. 
Tissue sections were evaluated for fluorescence and for the form of 
deposition on the GBM. Neonatal mice of the three species were evalu-
ated on day 0, 5, 10, 15, and 20. Two litters were tested \'lith each 
antiserum. 
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3. Urine protein determination after injection with an anti-GBM anti-
serum. 
Urine was collected from 3 adult Swiss white mice. The animals 
were given food and water for 25 hours and their urine was collected 
over 5 consecutive days. Urine volume was found to decline signifi-
cantly. It was then decided that the animals would be given food and 
water on days prior to but not on the day of urine collection. Con-
trol urines were collected 5 times for each of the three mice. 
Urine volumes were measured and protein content determined by sul-
fosalicylic acid precipitation. A 3% SSA solution was mixed with 0.5 
ml mouse urine. This solution was read after 5 minutes at 660 m~ 
(Coleman Junior II Model 6/20) and compared to a urine and saline blank. 
Protein content was determined by comparison to calorimetric changes 
induced by known quantities of albumin. 
After collection of control urines, the animals were injected with 
0.2 ml of antiserum 20, anti-whole GBM. Urine was collected for 24 hour 
periods on days 1, 3, 5, 7, and 9. The animals were then sacrificed 
and kidneys, hearts, liver and lung were removed and prepared as des-
cribed above. 
Control mice were injected with NRS and ~aline in this manner and 
evaluated for immunofluorescence. 
G. Carbohydrase treatment of kidney sections 
Several carbohydrase preparations were employed. The first was 
derived from Streptococcus mutans by Dr. J. Hayashi, Department of 
Biochemistry, Presbyterian St. Lukes Medical Center, Chicago, Illinois. 
The carbohydrase (CHO-ase) is a lyophilized mixture of glucosidase, 
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s-galactosidase, neuraminidase, fucosidase, and hexosaminidase. The 
second enzyme preparation was commercially purified by Sigma, St. Louis, 
Mo. The enzymes were neuraminidase, fucosidase, a-glucosidase, s-glu-
cosidase, s-galactosidase and mannosidase. 
Mouse and human kidney tissue section were incubated at 37°C in a 
solution of 0.2% CHO-ase for 12 hours. Toluene, penicillin G, and 
sodium azide were added to the enzyme mixtures for control of bacterial 
growth. Tissue sections were also incubated without these inhibitors 
and evaluated for fluorescence with no discernible variation. Commer-
cially prepared enzymes were used in 0.1 enzyme quantities per 20 cc of 
PBS. Neuraminidase was used in 0.02% solution of PBS. After 12 hours 
incubation, slides were washed in PBS as described earlier. Enzymes 
were incubated with their substrates for various periods of time and at 
various temperatures to determine optimum conditions for treatment of 
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kidney tissue sections. Products of enzyme activity were evaluated by 
Benedict's Test, thin layer chromatography, and by comparison of fluor-
escent activity. Sialic acid was determined by the thiobarbituric acid 
method (30). 
Normal, untreated tissue was evaluated after storage in the cold, 
in PBS at 37°C, and in a moist chamber at 37°C and used as controls 
during the evaluation of all antisera. Human and mouse, adult and neo-
natal tissues were evaluated. Sections of kidney tissue were incubated 
with enzymes individually, in pairs, in threes, in fours, and all 
together. Antisera previously described were used in the immunofluor-
escent evaluations. 
/ 
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Sequential enzyme studies were attempted by breakdown of tissue 
and resultant increase in non-specific immunofluorescence was excessive 
because of the 12 hour incubation periods previously determined to be 
optimum. 
H. Photography 
Color slides were taken of all kidney tissue sections during the 
in vivo experiments using immunofluorescence. Slides were also taken of 
any positive fluorescence obtained during the in vitro screening of 
antisera or evaluation of carbohydrase treated sections. A Leica 
camera (Ernst Leitz, Wetzlar, Germany) .mounted on a Leitz fluorescent 
microscope was used to take color slides. The film used was 35 mm GAF 
500 (GAF Corp., New York, N.Y.) ASA500, at 35 seconds exposure time. 
Use of the constant time allowed for the additional evaluation of the 
slides for comparisons of the intensity of the fluorescence. 
CHAPTER III 
RESULTS 
A. Indirect fluorescent antibody tests 
Indirect fluorescent antibody tests were performed on a) 4 normal 
human kidneys (NHK) (3 adult and 1 neonate) and b) 3 species of adult 
mice: Swiss white, C3H, and C57Bl and Swiss white neonatal mice. 
Tissues were graded -, +, 1+, 2+, 3+, and 4+ as shown in Plate I ' 
All values are the result of tests on 2 or more different mice or 
repeated evaluation of the human kidneys. Plate II demonstrates linear 
and granular fluorescent staining patterns. 
As described in Chapter II untreated and carbohydrase treated 
tissue sections were evaluated after incubation with selected antisera. 
Tissues were evaluated for changes of at least one degree of fluore-
scence between untreated and carbohydrase treated sections. Increases 
were observed as follows: - to +, + to 1+, 1+ to 2+, 2+ to 3+, 3+ to 
4+. Increases of more than one unit did take place. Decrease in fluor-
escence after carbohydrase treatment was also determined by units. 
B. Screening of anti-SCM and anti-GBM antise~a against NHK, either 
untreated or carbohydrase treated tissue sections 
The carbohydrase used in all the screening processes was a com-
bination of commercially prepared enzymes including neuraminidase, a-
glucosidase, a-glucosidase, s-galactosidase, mannosidase and fucosidase. 
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1. Screening of anti-SCM antisera directed against whole SCM or antigen 
fractions of SCM found to be high in protein content. 
Of the 11 antisera observed, select sera showed increases in 
immunofluorescence as defined above. Antisera A38, A39, A40, A43a, A44, 
and A45 showed increased immunofluorescence with adult human kidney 
tissue sections after carbohydrase treatment. Antiserum A40 showed 
decreased reactivity with NHK-3 after carbohydrase treatment. Antisera 
A40, A43a, A43b, and A47 showed increased immunofluorescence after 
carbohydrase treatment of the neonatal human kidney (NHK-4). Antisera 
A38 showed decreased fluorescence after carbohydrase treatment of the 
neonatal kidney. 
The four NHK were observed to differ somewhat in their degree of 
immunofluorescent reactivities. NHK-1 and NHK-4 (neonatal) showed 
greater changes after carbohydrase treatment (5 of 11 antisera). NHK~3 
showed unit changes in fluorescence \'lith 4 of 11 antisera. NHK-2 
showed the least variation with 2 of 11 antisera. In general neonatal 
tissue showed greater fluorescence of untreated tissue than did the 
adult. These values are given in Table 3. 
2. Screening of anti-GBM antisera directed against \'/hole GBM or anti-
gen fraction of GBM found to be high in protein content. 
The values obtained when NHK was screened by anti-GBr~ 11protein 11 
antisera are given in Table 4. 
The greatest reactivity was observed with those antisera directed 
against whole GBM such as antiserum 20. Antisera 16 and 29 showed an 
increased fluorescence with 3 of the NHK examined, while failing to 
show an increase with NHK-3. Antisera 21 showed an increased reactivity 
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with 2 of the NHK, and antisera 20 and 27 showed an increase with only 
1 of the kidneys. Antisera A29 and 24 failed to show increased fluore-
scence under these test conditions. 
NHK-1, NHK-2 and NHK-4 (neonatal) increased in fluorescence with 
4 of the 8 antisera evaluated. NHK-3 showed the least reactivity, 
variation with 1 of 8 antisera tested. 
3. Screening of anti-SCM antisera directed against SCM fractions high 
in carbohydrate content. 
The immunofluorescent reactivity of antisera directed against 
carbohydrate determinants of SCM is shown in Table 5. 
Three NHK adult and a single neonate were examined. There was a 
general lack of reactivity change observed between untreated and carbo-
hydrase treated kidney sections with the exception of the pooled anti-
SCM versus NHK-2. Reactivity was lost upon treatment with carbohydrase. 
NHK-1, NHK-3, and NHK-4 (neonatal) were found to be unreactive. 
4. Screening of anti-GBM antisera directed against GBM fractions high 
in carbohydrate content. 
As indicated in Table 6, antisera A3lb showed a decrease in immuno-
fluorescence with a 11 of the NHK. Anti sera 1138, 1139, and 1152 were 
found to react to a lesser degree with NHK-1 ~nd NHK-2, but showed a 
decrease in immunofluorescence upon carbohydrase treatment of NHK-3 and 
NHK-4 (neonatal). Antiserum A3la showed a decrease in reactivity upon 
carbohydrase treatment of the tissue in NHK-2, NHK-3, and NHK-4; while 
A33 showed a decrease in NHK-1, NHK-2, and NHK-3. Pooled GBM antisera 
remained relatively unreactive. 
23 
C. Screening of anti-SCM and anti-GBM antisera against NMK of 3 species: 
Swiss white, C3H, and C57Bl, either untreated or carbohydrase treated 
tissue sections 
Mouse tissues were treated and observed for the same changes that 
were found in human studies. 
1. Screening of antigen fractions of SCM found to be high in protein 
content. 
Of the 11 antisera evaluated in Table 6, 7 showed no significant 
variation in immunofluorescence after carbohydrase treatment;these anti-
sera are A37, A38, A39, A41, A43b andA45. Antiserum A40 alone showed 
increased fluorescence with 3 of the 4 tissues: Swiss adult, Swiss neo-
nate, and C3H. Antiserum A43a showed an increase with Swiss adult and 
C57Bl. Antiserum A44 showed an increase with C3H and C57Bl. Antiserum 
47 showed an increase with C3H. 
The three species of mice studies were found to differ in their 
degree of immunofluorescent reactivities and to be generally less reac-
tive than the NHK previously studied. C3H showed an increase in reac-
tivity with 3 of the 11 antisera. Swiss adult and C57Bl showed an 
increase with 2 of the 11 selected sera. Swiss neonate showed an 
increase with 1 of 11 selected sera. 
2. Screening of anti-GBM antisera dire~ted against whole GBM or antigen 
fractions of GBM found to be high in protein content. 
Of the 8 antisera observed in Table 8, 4 {27, A29, 24, and NRS) 
showed no significant variation in immunofluorescence after carbohydrase 
treatment of the mouse tissue. Antisera 16 and 21 showed a decrease 
after the tissue was treated with carbohydrase in Swiss adult tissue. 
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A+ to- change was also observed in the C3H and C57Bl. Antisera 29 
and 20 showed an increase in fluorescence after carbohydrase treatment 
with Swiss adult and C3H. Antiserum 29 also showed an increase in 
C57Bl. 
Swiss white adult showed immunofluorescent variation after carbo-
hydrase treatment with 4 of the 8 selected sera. Swiss neonate showed 
no variation after carbohydrase treatment. C3H showed an increase' with 2 
of the antisera while C57Bl showed a similar variat1on with 1 antiserum. 
3. Screening of anti-SCM antisera directed against SCM fractions high 
in carbohydrate content. 
A general lack of reactivity was observed for all antisera and NMK 
evaluation. No increase or decrease in fluorescence was observed follow-
ing carbohydrase treatment as observed in Table 9. 
4. Screening of anti-GBr·1 antisera directed against GBr~ fractions high 
in carbohydrate content. 
Table 10 shows the immunofluorescent reactivity of 9 selected sera 
to NMK. Antisera A3la, A3lb, 1156 and GBM pooled showed no significant 
immunofluorescent reactivity. Antisera A33 showed a decrease in reac-
tivity after carbohydrase treatment in 2 species, C3H and C57Bl. Anti-
serum 1139 showed a decrease only in the C3H species. 
C3H and C57Bl adult mice appeared to be more reactive than the 
Swiss white adult. The Swiss neonatal tissue was essentially non-reac-
tive. 
D. Indirect fluorescent antibody evaluation of mouse liver, lung, and 
heart tissue both untreated and carbohydrase treated 
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Table 11 lists the antisera evaluated against carbohydrase and 
non-carbohydrase treated mouse liver, lung and heart of three species. 
No fluorescent reactivity was found. 
E. In vivo mouse evaluations 
Adult mice of three species, Swiss white, C3H and C57Bl were 
injected with selected antisera and evaluated for immunofluorescence 
in the following organs: kidney, liver, lung, and heart. In addition, 
neonatal mice were evaluated for changes in fluorescence over the first 
month of their .lives. 
1. In vivo evaluation of adult mice of three species: Swiss white, 
C3H, and C57Bl. 
Table 12 lists the degree of immunofluorescence after selected sera 
were injected into mice. IP and IV injections of antisera into Swiss 
white adult were found to give essentially the same degree of immuno-
fluorescence as those found in the untreated Swiss white adult tissues 
during the screening process. IV injection of antisera was used in the 
C3H and C57Bl studies. These were found to be essentially equivalent 
to the untreated tissues previously discussed. Anti-GBM 11 protein 11 
antisera (16, 20, and 21) gave the greatest reactivity. 
Antiserum 16 reacted to the same degree with the adult Swiss white 
and C3H species; C57Bl failed to react significantly under these condi-
tions. Antiserum 20 was highly reactive with the Swiss white species 
and less so with C3H and C57Bl. Antiserum 21 again showed greater 
reactivity with the Swiss white species. 
Linear deposition was observed with the anti-GBM antisera. Depo-
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sition of the singly reactive anti-SCM antisera, A43a, was not identi-
fiable. No fluorescence was observed in mouse liver, lung or heart 
sections. 
Several of the mice were notably lethargic after injection with 
antiserum 20. 
2. In vivo evaluation of neonatal mice of three species: Swiss white, 
C3H and C57Bl. 
Evaluation of neonatal mice after IP injection of anti-SCM and 
anti-GBM is shown in Table 13. Litter mates \'Jere tested on day 0, 5, 
10, 15, 20, and 25. Antiserum 16 showed reactivity in the Swiss white 
after 10 days and in the C3H after 15 days. This antiserum failed to 
show reactivity with the C57Bl as far as the 25th day. Antiserum 20 
appeared to be positive after 5 days in the Swiss white, and was reac-
tive from day 0 in the other 2 species. Antiserum 21 showed minimal 
reactivity with the Swiss white mice after 25 days and no reactivity 
in the other species as far as the 25 day termination. All depositions 
were linear in nature. 
3. Urine protein determination after injection with an anti-GBM anti-
serum. 
Table 14 shows the urine volume and protein determinations of 
Swiss white adult mice after injection with anti-whole GBM, 20. Little 
variation in urine volume was noted over the 9 day test period. No 
protein was detectable. After sacrifice all three mice were observed to 
have 3+ fluorescence in kidney tissue sections and no detectable reac-
tivity in liver, lung or heart tissue. 
F. Carbohydrase treatment of NHK tissue sections and evaluation by 
immunofluorescence of anti-SCM and anti-GBM antisera 
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NHK was prepared as described in Chapter 2, section H. Controls 
were run and determined to be correct. 
1. Anti-SCM "protein .. antisera versus tissues incubated in selected 
carbohydrase solutions. 
Table 15 shows the fluorescent evaluations of 3 anti-SCM .. protein" 
directed antisera. Generally, the carbohydrase combinations either 
containing neuraminidase or containing 4 different enzymes were observ-
ed to show increased fluorescence after carbohydrase treatment, show-
ing similarity to the tissue incubated with all the enzymes as seen in 
the screening experiments. 
This increase over the untreated tissue is shown with antiserum 
A44 in the adult NHK. No similar change was noted with neonatal NHK. · 
Antisera A40 and A43a appeared to show little variation in adult NHK. 
However, these antisera did show such an increase in reactivity with 
neonatal tissue for those enzyme combinations described above. 
2. Anti-GBM "protein .. antisera versus tissues incubated in selected 
carbohydrase solutions. 
Table 16 lists the fluorescent evaluatiOIJ of 4 anti-GBM "protein" 
directed antisera. Antiserum 16 was found to increase in fluorescence 
after treatment with the above mentioned combinations of enzymes in the 
adult NHK, but not in the neonatal. In the adult NHK antiserum 20 
showed decreased fluorescence with 2 enzyme combinations, N,s-gal and 
N1a-glu. In the neonatal NHK no variation in reactivity w~s noted. 
Antiserum 21 again showed an increase in fluorescence after carbohydrase 
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treatment with combinations containing N or 4 or more enzymes in the 
adult. No variation was noted in the neonate. Antiserum 29 showed in-
creases similar to those shown with antiserum 21 in the adult. Unlike 
antiserum 21, antiserum 29 showed an increase in fluorescence after 
carbohydrase treatment with 2 combinations: a-gal a-glu a-glu man fuc 
and a-gal a-glu a-glu man as well as with the combination of all carbo-
hydrases. 
3. Anti-SCM "carbohydrate" antisera versus tissues incubated in 
selected carbohydrase solutions. 
Table 17 lists the result of testing 3 anti-SCM "carbohydrate" 
antisera. No immunofluorescent reactivity was noted. 
4. Anti-GBM 11Carbohydrate" antisera versus tissues incubated in select-
carbohydrase solutions. 
Significant immunofluorescent reactivity was lost when anti-GBM 
11 carbohydrate" antisera incubated with NHK tissues having undergone 
carbohydrase treatment with combinations containing N and with combina-
tions of 4 or more enzymes as shown in Table 18. Antiserum 1138 showed 
a decrease in fluorescence as described above. In addition, antiserum 
1138 showed a similar decrease for those combinations containing 3 en-
zymes. Antiserum 1152 showed a decrease in fluorescence as described 
above. In addition a decrease was noted for all other enzyme combina-
tions. GBM pooled antiserum showed no reactivity in the adult NHK and 
only reacted positively with the untreated neonatal NHK tissue. 
G. Carbohydrase treatment of M4K tissue sections and evaluation by 
immunofluorescence of anti-SCM and anti-GBM antisera 
Control tissues were determined to be correct. 
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1. Anti-SCM "protein" antisera versus tissues incubated in selected 
carbohydrase solutions. 
Table 19 lists the reactivity of S\1iss \'lhite, adult and neonatal 
mice to 3 selected antisera. Antiserum A40 showed an increase in 
fluorescence after carbohydrase treatment with combinations of N with 
at least 2 other enzymes, N s-gal, s-glu man, s-glu fuc, a-glu fuc, 
fuc man, 3 enzymes without N, and 4 or more enzymes without N in the 
adult NMK. The variation found in the neonatal NMK was more complex 
than the adult. Antiserum A40 lost reactivity in the neonate vlith N s-
gal, s-gal man and fuc man. An increase in fluorescence was found 
after incubation of neonatal NMK with combinations of carbohydrase 
containing 4 or more enzymes, a-glu s-glu fuc, and all those combina-
tions containing N with 2 other enzymes except N s-gal s-glu. Anti-
serum A43a showed an increase after carbohydrase treatment of adult 
mouse tissue for 5 combinations of enzymes: N s-gal s-glu, N s-gal man, 
s-gal a-glu s-glu, and for combinations of 4 or more enzymes containing 
man. In the neonatal NMK, antiserum A43a failed to show any signifi-
cant change in fluorescence after carbohydrase treatment. Antiserum 
A44 failed to show any significant variation in fluorescence in either 
adult or neonatal mouse. 
2. Anti-GBM "protein" antisera versus tissues incubated in selected 
carbohydrase solutions. 
Table 20 shows the immunofluorescent reactivity of 4 selected anti-
sera. Antiserum 16, when incubated with NMK adult tissue showed a 
decrease in fluorescence after carbohydrase treatment with N B-gal man 
only and no fluorescent reactivity in the neonatal mouse. Antiserum 21 
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showed a decrease in fluorescence of the NMK adult tissue after incuba-
tion with all enzyme combinations. In the neonatal mouse, antiserum 
21 showed a decrease in fluoresence after treatment with N and a-gal 
a-glu man. Antiserum 21 showed a decrease in fluorescence after 
carbohydrase treatment of the adult N~tK for all enzyme combinations. 
No fluorescent reactivity was noted in the neonate. Antiserum 29 show-
ed an increase in fluorescence in the NMK adult after carbohydrase 
treatment with combinations containing N or 3 or more enzymes. Anti-
serum 29 did not show a change in fluorescence after carbohydrase 
treatment of the neonatal mouse. 
3. Anti-SCM 11Carbohydrate 11 antisera versus tissues incubated in 
selected carbohydrase solutions. 
Table 21 lists the result of testing 3 anti-SCM 11Carbohydrate" 
antisera. No immunofluorescent reactivity was noted. 
4. Anti-GBM 11Carbohydrate" antisera versus tissues incubated in 
selected carbohydrase solutions. 
" Table 22 lists the result of testing 3 anti-GBM "carbohydrate .. 
antisera. No immunofluorescent reactivity was noted. 
Plate I. Glomerular Staining Intensities. 
B (before) represents the immunofluorescence of the 
untreated NHK tissue. 
A (after) represents the immunofluorescence of the 
carbohydrase treated NHK tissue. 
The top two glomeruli demonstrate an increase in 
immunofluorescence from 2+ to 4+ after carbohydrase 
treatment. The antiserum was directed against the 
protein determinants. 
The bottom two glomeruli demonstrate an increase in 
immunofluorescence from l+ to 3+ after carbohydrase 
treatment. The antiserum was directed against the 
protein determinants of GBM. 
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Plate II. Glomerular Staining Intensities. 
G represents granular staining of 1+ immunofluore-
scence. 
L represents linear staining of 4+ immunofluore-
scence. 
* Color photography does not represent the true intensity as 
observed visually with the use of a fluorescent microscope~ 
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Table 1. Comparison of Pharyngitis-Associated 
Feature 
Clinical & 
pathological 
Familial 
occurrence 
·Prognosis 
Recurrences 
Season 
Geographical 
distribution 
Age 
Sex 
Latent period 
Attack rate* 
and Pyoderma-Associated Acute Nephritis (37) 
Pharyngitis-Associated 
Acute Nephritis 
No difference 
Common 
Generably favorable 
Rare 
Winter & Spring 
North & South 
Early school age 
2 males; 1 female 
10 days 
10-15% 
Pyoderma-Associated 
Acute Nephrites 
No difference 
Common 
Generably favorable 
Rare 
Late summer & early 
Predominantly South 
Preschool age 
Equally distributed 
3 weeks 
10-15% 
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fall 
Serological 
types Limited types Also limited, but different 
types 
Streptococcal 
antibody_response Generally good Variable, depending on 
.antigen 
* After infection with known nephritogenic strain. 
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Table 2. Antisera Specificity and Immunogens 
Anti-carbohydrate antisera 
Anti-SCM 
1140 
1141 
1142 
1145 
.1146 
1147 
1148 
1149 
CM pool 
1153 
1155 
Anti-protein antisera 
Anti-SCM 
A37 SLS CM 
A38 who 1 e SCM 
A39 CM12-citrate extracted 
A40 CM12-citrate extracted 
A41 supernatant CnBrCM 
A43a supernatant CnBrSLSCM 
A43b supernatant CnBrSLSCM 
A44 pepsin CnBrCM 
A45 pepsin CnBrCM 
A47 pepsin CnBrSLSCM 
Anti -GBM 
A3la 
A31b 
A33 
1138 
1139 
1152 
1156 
GB~1 pool 
Anti-GBM 
16 whole HGBM 
27 supernatant CnBr SLSGBM 
21 supernatant CnBr SLSGBM 
29 whole GBM 
A29 whole GBM 
24 GBM SLS CnBr 
20 PGT HUGLI I 
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Table 3. Indirect Fluorescent Antibody Tests* 
Anti~streptococcal cell membrane protein epitopes vs. normal human 
kidney NHK; untreated (U) and carbohydrase (C) treated tissue sections. 
Antisera NHK-1 NHK-2 NHK-3 NHK-4* 
u c u c u c u c 
A37 + + + 
A38 + 1+ + 1+ +- + 1+ + 
A39 + 1+ + l+ 
A40 l+ 1+ + 1+ 2+ 
A41 + + + + + 
A43a + + + 2+ +- 2+ 
A43b +- + + + + + 2+ 
A44 + 2+ + 1+ 1+ 1+ 
A45 + + + 1+ 
A47 +- +- + + + 1+ 
NRS 
*All readings were ranked from neg (-) or trace reactive+ or+- to 
reproducible graded fluorescence of 1+ to 4+ (see Plate I}. These 
determinations apply to Table 4 through 22. 
** NHK-4 represents the neonatal human kidney in all tables. 
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Table 4. Indirect Fluorescent Antibody Tests 
Anti-human GB~1 Protein epitopes vs. normal human kidney; Untreated (U) 
and carbohydrase (C) treated tissue sections. 
Antisera NHK-1 NHK-2 NHK-3 NHK-4 
u c u c u c u c 
16 1+ 2+ + 1+ 1+ + + 1-2+ 
27 1+ 1+ + + + + 1+ 2+ 
21 l+ 2+ + 1+ + + 1+ 1+ 
29 1+ 2+ + 2+ + + + 1+ 
A29 + + + 
24 + 
20 3+ 3+ 1+ 1+ 1+ 1+ 1+ 2+ 
NRS 
Table 5. Indirect Fluorescent Antibody Tests 
Anti-streptococcal cell membrane carbohydrate vs. normal human kidney 
(NHK); untreated (U) and carbohydrase (C) treated tissue sections. 
Antisera 
1140 
1141 
1142 
1145 
1146 
1147 
1148 
1149 
CM pool 
1153 
1155 
NHK-1 
u c 
+-
+ 
+-
+-
NHK-2 
u c 
+ 
+ 
+ 
+ 
1+ 
NHK-3 NHK-4 
u c u c 
+ 
+ 
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Table 6. Indirect Fluorescent Antibody Tests 
Anti-human GBM carbohydrate vs. normal human kidney (NHK); untreated 
{U) and carbohydrase (C) treated tissue sections. 
Antisera NHK-1 NHK-2 NHK-3 NHK-4 
u c u c u c u c 
A31a 2+ 2+ 1+ 2+ + 1+ 
A31b 4+ 3+ 3+ 2-3+ 3-4+ 2-3+ 2-3+ 3+ 
A33 2+ 1+ 2-3+ + 2..,.3+ 1+ 2-3+ 3+ 
1138 +- 1-2+ 1+ 1+ +-
1139 + l+ + 1+ 1+ 
1152 1+ + 1+ + 
GBM pool +- +- +-
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Table 7. Indirect Fluorescent Antibody Tests 
Anti-streptococcal cell membrane protein epitopes vs. normal mouse kid-
ney; untreated (U) and carbohydrase (C) treated tissue sections. 
Antisera Swiss adult Swiss neonate C3H C57B1 
u c u c u c u c 
A37 
A38 +- + l+ 1+ + + 
A39 + + + + + + 
A40 1+ 1+ 2+ + 1+ 1+ 1+ 
A41 + + + + + 
A43a + 1+ + + 2+ 2+ + 1+ 
A43b + + + + 
A44 + + + + 1+ + 1+ 
A45 + + + + + + 
A47 + + + 1+ + 
NRS 
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Table 8. Indirect Fluorescent Antibody Tests 
Anti-human GBM protein epitopes vs. normal mouse; untreated (U) and 
carbohydrase (C) treated tissue sections. 
Antisera Swiss adult Swiss neonate C3H C57Bl 
u c u c u c u c 
16 1+ + + + + + 
27 1-2+ 1+ + + 
21 1+ + + + 
29 + 1+ 1+ 1+ + 1+ 1+ 
A29 1+ 1+ 2+ 2+ 1+ 1+ 
24 1+ 1+ 2+ 2+ 1+ l+ 
20 1+ 3+ 1-2+ 2+ +-1+ 1+-2+ 
NRS 
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Table 9. Indirect Fluorescent Antibody Tests 
Anti-streptococcal cell membrane carbohydrase vs. normal mouse kidney; 
untreated (U) and carbohydrase (C) treated tissue sections. 
Antisera 
1140 
1141 
1142 
1145 
1146 
1147 
1148 
1149 
CM pool 
1153 
1155 
Swiss adult 
u c 
Swiss neonate C3H C57Bl 
u c u c u c 
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Table 10. Indirect Fluorescent Antibody Tests 
Anti-human GBM carbohydrate vs. normal mouse kidney; untreated {U) and 
carbohydrase {C) treated tissue sections. 
Antisera Swiss adult Swiss neonate C3H C57Bl 
u c u c u c u c 
A3la + 
A3lb + + + 
A33 l+ + l+ + l+ 1+ 
1138 +- 1-2+ 1+ l+ +-
1139 + 1+ + 1+ 1+ 
1152 1+ + 2+ + 
1156 + + + 
GBM pool +- +- + 
Table 11. Indirect Fluorescent Antibody Tests 
Anti-carbohydrate antisera 
Anti-SCM 
1140 
1141 
1142 
1145 
1146 
1147 
1148 
1149 
Cm pool 
1153 
1155 
Anti-GBM 
A3la 
A3lb 
A33 
1138 
1139 
1152 
1156 
GBM pool 
Swiss 'llh ite 
H L i Lu 
Anti-protein antisera 
Anti-SCM 
A37 
A38 
A39 
A40 
A41 
A43a 
A43b 
A44 
A45 
A47 
AntiGBM 
16 
27 
21 
29 
A29 
24 
20 
NRS 
tl -
C3H C57Bl 
H Li Lu H Li Lu 
-· 
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S'11i ss neonate 
H Li Lu 
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Table 12. In Vivo Fluorescent Antibody Tests in 
Adult Mice of 3 Species: Swiss white, 
C3H and C57Bl, evaluation of kidney. 
Antisera Swiss white C3H C57Bl 
IP IV IV IV 
16 l+t* l+t l+t + 
20 3+t 3+R. l+R. l+t 
21 1 +R. l+R. + + 
29 +R. + + 
1138 1+ 
1152 2+ 
A40 + + 
A43a + 1+ + 
A44 + + + 
* t represents linear deposition. 
Antisera 
0 
16 
20 -
21 
-
29 
-
1138 -
1152 -
A40 
Table 13. In Vivo Fluorescent Antibody Tests in 
Neonatal Mice of 3 Species, Studies of 
Litter Mates, evaluation of kidneys. 
Swiss white C3H C57Bl 
days days days 
5 10 15 20 25 0 5 10 15 20 25 0 5 l 0 15 
+.R.* +.R. +.R. +.R. 
-
+t +t +.R. 
- - - -
+.R. +t +t l+t 1+t +t +t +t +t +t +i +.R. +i +i +.R. 
- -
+.R. 
-
- - - - -
A43a - - -
A44 
* t represents linear deposition. 
45 
20 25 
+i +t 
Each value given is the average of two mice from two different litters. 
46 
Table 14. In Vivo Fluorescent Antibody Tests 
Anti-whole human GBM, 20, vs. Swiss white mouse adult, urine protein 
determinations. 
Fluorescence IgG* 
Mouse 
1 urine volume ml 
protein** 
2 urine volume ml 
protein 
3 urine volume ml 
protein 
* K: Kidney 
Li: Liver 
Lu: Lung 
H: Heart 
Day 1 
0.7 
0 
0.6 
0 
0.7 
0 
3 5 7 9 
0.5 0.6 0.6 0.6 
0 0 0 0 
0.6 0.6 0.5 0.5 
0 0 0 0 
0.7 0.6 0.6 0.6 
0 0 0 0 
**Protein content of less then 16 mg% was read as 0. 
K Li Lu H 
3+ 
-
3+ -
3+ 
-
3+ 
-
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Table 15. Indirect Antibody Tests 
Anti-SCM 11 protein" vs. NHK: untreated and carbohydrase treated. 
NHK-1 Neonate 
Enzyme Used Antisera: A40 A43a A44 A40 A43a A44 
Untreated + + + 1+ + l+ 
CHO-ase + 2+ 2+ 2+ 1+ 
N + 1+ 1+ 1+ 1+ 
s gal + + 1+ + 1+ 
a glu + + 1+ + 1+ 
S glu + + l+ + l+ 
t·1an + + 1+ + 1+ 
Fuc + + l+ + l+ 
N, s gal + l+ l+ 1+ 1+ 
N, a glu + 1+ 1+ + l+ 
N, S glu + 1+ 1+ l+ 1+ 
S gal, a glu + 1+ 1+ + l+ 
s gal, S glu + 1+ l+ + 1+ 
S gal, man + l+ 1+ + 1+ 
s gal, fuc + 1+ 1+ + 1+ 
N, s gal, a glu + 2+ 2+ 2+ 1+ 
N,egal,sglu + 2+ 2+ 2+ 1+ 
N, S gal, man + 2+ l+ 2+ 1+ 
N, a gal, fuc + 2+ l+ 1+ 1+ 
a gal, CL glu, a glu + 2+ l+ 1+ 1+ 
a gal, C'L glu, man + 2+ l+ 1+ 1+ 
a gal, C'L glu, fuc + 1+ 1+ 1+ 1+ 
CL glu, a glU, man + 2+ l+ 1+ 1+ 
CL glU, a glu, fuc + 1+ 1+ 1+ l+ 
CL glU, a g1U + 1+ 1+ 1+ 1+ 
a glu, man + 1+ 1+ + 1+ 
e gl u, man + 1+ 1+ + 1+ 
a glu, fuc + + 1+ + 1+ 
a g1u, fuc + + 1+ + 1+ 
fuc, man + + 1+ + 1+ 
S gal, a glu, e glu, man, fuc - + 1+ 2+ 2+ 1+ 
B gal, a glu, a glu, man + 2+ 2+ 2+ 1+ 
B gal, a glu, s gl u' fuc + 1+ 2+ 2+ l+ 
Abbreviations: N = neuraminidase 0.2%; 0.1 unit of the following: 
gal = galactosidase, glu = glucosidase, man = mannosi-
dase, fuc = fucos i dase; CHO-ase = carbohydrases together. 
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Table 16. Indirect Antibody Tests 
Anti-GBM 11 protein 11 vs. NHK: untreated and carbohydrase treated. 
NHK-1 Neonatal 
Enzyme Used Antisera: 16 20 21 29 16 20 21 29 
Untreated l+ 3+ 1+ l+ + 1+ 1+ + 
CHO-ase 2+ 3+ 2+ 2+ 1+ 2+ 1+ l+ 
N l+ 3+ 1+ 1+ + 1+ 1+ + 
s gal 1+ 3+ 1+ 1+ + 1+ 1+ + 
a glu 1+ 3+ 1+ 1+ + 1+ 1+ + 
s glu 1+ 3+ l+ l+ + 1+ 1+ + 
Man 1+ 3+ 1+ l+ + 1+ 1+ + 
Fuc 1+ 3+ 1+ 1+ + 1+ 1+ + 
N, S gal 2+ 2+ 2+ 2+ + 1+ 1+ + 
N, a glu 1+ 2+ 1+ 2+ + 1+ 1+ + 
N, S glu 1+ 3+ 2+ 2+ + 1+ 1+ + 
S gal, a glu 1+ 3+ l+ l+ + 1+ 1+ + 
B gal, S glu 1+ 3+ 1+ 1+ + 1+ 1+ + 
8 gal, man 1+ 3+ 1+ 1+ + 1+ 1+ + 
B gal, fuc 1+ 3+ 1+ 1+ + l+ 1+ + 
N, S gal, a glu 2+ 2+ 2+ 2+ + 1+ 1+ + 
N, S ga 1 , S g 1 u 2+ 3+ 2+ 2+ + 1+ 1+ + 
N, 8 gal, man 2+ 3+ 2+ 1+ + 1+ 1+ + 
N, 8 gal, fuc 2+ 3+ 1+ 1+ + 1+ 1+ + 
B gal, a glu, 8 glu 2+ 3+ l+ 1+ + l+ 1+ + 
S gal, a glu, man 2+ 3+ 1+ 1+ + 1+ 1+ + 
B gal, a glu, fuc 2+ 3+ 1+ l+ + 1+ 1+ + 
a glu, S g1u, man 2+ 3+ 1+ l+ + 1+ 1+ + 
a glu, S glu, fuc 1+ 3+ 1+ l+ + 1+ 1+ + 
a glu, 8 glu 1+ 3+ 1+ 1+ + l+ 1+ + 
a glu, man 1+ 3+ l+ 1+ + 1+ 1+ + 
s gl u' man l+ 3+ l+ l+ + 1+ l+ + 
s gl u' fuc 1+ 3+ 1+ l+ + l+ 1+ + 
a glu, fuc 1+ 3+ 1+ l+ + 1+ l+ + 
fuc, man 1+ 3+ l+ 1+ + l+ 1+ + 
s ga 1, a glu, 8 glu, man, fuc 2+ 3+ 2+ 2+ 1+ 1+ 1+ 1+ 
B gal, a glu, 8 glu, man 2+ 3+ 2+ 2+ 1+ 1+ 1+ 1+ 
B gal, a glu, B glu, fuc 2+ 3+ 2+ 1+ + 1+ 1+ + 
Abbreviations: N = neuraminidase 0.2%; 0.1 unit of the following: gal = 
galactosidase, glu = glucosidase, man = mannosidase, 
fuc = fucosidase; CHO-ase = carbohydrases together. 
Table 17. Indirect Antibody Tests 
Anti -SC~1 .. carbohydrate 11 vs. NHK: untreated and carbohydrase treated. 
Enzyme Used 
NHK-1 
Antisera: 1140 1142 CM 
Untreated +- +-
CHO-ase 
N 
8 gal 
a glu 
8 glu 
Man 
Fuc 
N, 8 gal 
N, a glu 
N, 8 glu 
8 gal, a glu 
8 gal, 8 glu 
8 gal, man 
8 gal, fuc 
N, 8 gal, a glu 
N, 8 gal, 8 glu 
N, 8 gal, man 
N, 8 gal, fuc 
8 gal, a glu, 8 glu 
8 gal, a glu, man 
8 gal, a glu, fuc 
a glu, 8 glu, man 
a glu, 8 glu, fuc 
a glu, 8 glu 
a glu, man 
8 glu, man 
s gl u, fuc 
a glu, fuc 
fuc, man 
s gal, a glu, s glu, man, fuc 
S gal, a glu~ s glu, man 
S gal, a glu, s glu, fuc 
Neonatal 
1140 1142 CM 
Abbreviations: N = neuraminidase0.2%; 0.1 unit of the following: 
gal = galactosidase, glu = glucosidase, man = man-
nosidase, fuc = fucosidase; CHO-ase carbohydrases 
together. 
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Table 18. Indirect Antibody Tests 
Anti-GBM .. carbohydrate" vs. NHK: untreated and carbohydrase treated. 
NHK-1 Neonatal 
·Enzyme Used Antisera: 1138 1152 GBM 1138 1152 GBM 
Untreated 3+ 
CHO-ase 2+ 
N 2+ 
8 gal 3+ 
a gl u 3+ 
8 gl u 3+ 
Man 3+ 
Fuc 3+ 
N, 8 gal 2+ 
N, a gl U 2+ 
N, 8 gl u 2+ 
8 gal, a glu 2+ 
8 gal, 8 glu 3+ 
S gal, man 3+ 
8 gal, fuc 3+ 
N, 8 gal, a glu 2+ 
N, S gal, S glu 2+ 
N, S gal, man 2+ 
N, s gal, fuc 2+ 
8 gal, a glu, S glu 2+ 
S gal, a glu, man 2+ 
S gal, a glu, fuc 2+ 
a glu, 8 glu, man 2+ 
a glu, S glu, fuc 2+ 
a glu, 8 glu 2+ 
a glu, man 3+ 
8 glu, man 3+ 
S glu, fuc 3+ 
a glu, fuc 3+ 
fuc, man 3+ 
8 gal, a glu, 8 glu, man, fuc 2+ 
S gal, a glu, S glu, man 2+ 
S gal, a glu, S glu, fuc 2+ 
2+ 
1+ 
1+ 
+ 
1+ 
1+ 
1+ 
+ 
+ 
+ 
1+ 
1+ 
1+ 
1+ 
+ 
+ 
+ 
+ 
1+ 
+ 
+ 
1+ 
1+ 
1+ 
+ 
+ 
+ 
+ 
Abbreviations: H = neuraminidase0.2%; 0.1 unit of the following: 
gal = galactosidase, glu = glucosidase, man = 
mannosidase, fuc = fucosidase; CHO-ase = carbo-
hydrases together. 
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Table 19. Indirect Antibody Tests 
Anti -SCM "protein" vs. NtvlK: untreated and carbohydrase treated. 
Swiss white Albino neonate 
Enzyme Used Anti sera: A40 A43a A44 A40 A43a A44 
Untreated + + + 1+ + + 
CHO-ase 1+ 1+ 2+ + + 
N + + + 1+ + 
8 gal + + + l+ + + 
a glu + + + 1+ + + 
8 glu + + + 1+ + + 
Man + + 1+ + + 
Fuc + + + + + 
N, 8 gal 1+ + + 1+ + + 
N, a glu + + + 1+ + + 
N, 8 glu + + + l+ + + 
N, man + + + 1+ + 
N, fuc + + + 1+ + + 
8 gal, a glu + + + 1+ + + 
8 gal, 8 glu + + + 1+ + + 
8 gal, man + + + + + + 
8 gal, fuc + + + 1+ + + 
N, a gal, a glu 1+ + + 2+ + + 
N,agal,aglu 1+ 1+ 1+ + + 
N, 8 gal, man 1+ 1+ 2+ + + 
N, a gal, fuc 1+ 1+ 2+ + + 
8 gal,. a glu, a glu 1+ 1+ 2+ + + 
a gal, Cl glu, man 1+ + 2+ + + 
a gal, Cl glu, fuc 1+ + 1+ + + 
Cl glu, a glu, man 1+ + 1+ + + 
a glu, a glu, fuc 1+ + + 2+ + + 
Cl glu, a glu 1+ + + 1+ + + 
a glu, man + + 1+ + + 
8 glu, man 1+ + 1+ + + 
a glu, fuc 1+ + 1+ + + 
a glu, fuc l+ + + 1+ + + 
fuc, man 1+ + + + + 
a gal, Cl glu, a gl u, man, fuc l+ + 2+ + + 
a gal, Cl glu, 8 glu, man 1+ l+ 2+ + + 
a gal, Cl glu, B glu, fuc 1+ + 2+ + + 
Abbreviations: N =neuraminidase 0.2%; 0.1 unit of the following: 
gal = galactosidase, glu = glucosidase, man = 
mannosidase, fuc = fucosidase; CHO-ase = carbohy-
drases together. 
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Table 20. Indirect Antibody Tests 
Anti-GBM "protein" vs. NMK: untreated and carbohydrase treated. 
Albino adult Albino neonate 
Enzyme Used Antisera: 16 20 21 29 16 20 21 29 
Untreated 1+ 3+ 1+ + 2+ 1+ 
CHO-ase + l+ 1+ 2+ l+ 
N 1+ 1+ + l+ 1+ 
B gal 1+ 1+ + 2+ 1+ 
a glu l+ 1+ + 2+ l+ 
B glu 1+ 1+ + 2+ l+ 
Man 1+ l+ + 2+ 1+ 
Fuc 1+ 1+ + 2+ 1+ 
N, s gal 1+ 1+ 1+ 2+ 1+ 
N, a glu 1+ 1+ 1+ 2+ 1+ 
N, s glu 1+ l+ 1+ 2+ 1+ 
N, man 1+ 1+ 1+ 2+ 1+ 
N, fuc 1+ l+ 1+ 2+ 1+ 
B gal, a glu l+ 1+ + 2+ 1+ 
8 gal, B glu l+ 1+ + 2+ 1+ 
8 gal, man 1+ 1+ + 2+ 1+ 
8 ga 1, fuc 1+ 1+ 1+ 2+ 1+ 
N, 3 gal, a g1u 1+ 1+ 1+ 2+ 1+ 
N,sgal,Sglu 1+ 1+ 1+ 2+ 1+ 
N, B gal, man + 1+ 1+ 2+ 1+ 
N, B gal, fuc 1+ 1+ l+ 2+ 1+ 
8 gal, a glu, B glu 1+ 1+ 1+ 2+ 1+ 
8 gal, a glu, man l+ l+ 1+ 1+ 1+ 
S gal, a glu, fuc 1+ 1+ 1+ 2+ 1+ 
a glu, f3 glu, man l+ 1+ + 2+ 1+ 
a glu, B glu, fuc 1+ 1+ 1+ 2+ 1+ 
a glu, S g1u 1+ l+ + 2+ 1+ 
a glu, man 1+ l+ + 2+ 1+ 
S glu, man 1+ l+ + 2+ 1+ 
s gl u' fuc 1+ l+ + 2+ 1+ 
a glu, fuc 1+ 1+ + 2+ 1+ 
fuc, man 1+ 1+ + 2+ l+ 
B gal, a glu, s glu, man, fuc l+ 1+ 1+ 2+ 1+ 
B gal, a glu, B glu, man 1+ 1+ 1+ 2+ 1+ 
B gal, a glu, B glu, fuc 1+ 1+ 1+ 2+ 1+ 
Abbreviations: N = neuraminidase0.2%; 0.1 unit of the following: 
gal = galactosidase, glu = glucosidase, man = mannosi-
dase, fuc = fucosidase; CHO-ase = carbohydrases together. 
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Table 21. Indirect Antibody Tests 
Anti-SCM 11 Carbohydrate 11 vs. NMK: untreated and carbohydrase treated. 
Enzyme Used 
Untreated 
CHO-ase 
N 
8 gal 
a glu 
8 glu 
Man 
Fuc 
N, 8 gal 
N, a glu 
N, 8 glu 
N, man 
N, fuc 
8 gal, a glu 
8 gal, 8 glu 
8 gal, man 
8 gal, fuc 
N, f3 gal, a glu 
N, 8 gal, 8 glu 
N, 8 gal, man 
N, 8 gal, fuc 
8 gal, a glu, 8 glu 
8 gal, a glu, man 
8 gal, a glu, fuc 
a glu, 8 glu, man 
a glu, 8 glu, fuc 
a glu, 8 glu 
a glu, man 
8 glu, man 
8 glu, fuc 
a glu, fuc 
fuc, man 
Albino adult 
Anti sera: 1140 1142 Ct4 
8 gal, a glu, 8 glu, man, fuc -
f3 gal, a glu, 8 glu, man 
8 gal, a glu, 8 glu, fuc 
Albino neonate 
1140 1142 CM 
Abbreviations: N = neuraminidase0.2%; 0.1 unit of the following: 
gal = galactosidase, glu = glucosidase, man = manno-
sidase, fuc = fucosidase; CHO-ase = carbohydrases 
together. 
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Table 22. Indirect Antibody Tests 
Anti-GBM 11 carbohydrate 11 vs. NMK: untreated and carbohydrase treated. 
Albino adult Albino neonate 
.Enzyme Used Antisera: 1138 1152 GBM 1138 1152 GBM 
Untreated + + 
CHO-ase 
N 
8 gal 
a glu 
8 glu 
Man 
Fuc 
N, 8 gal 
N, a glu 
N, 8 glu 
N, man 
N, fuc 
s gal, a glu 
8 gal, 8 glu 
8 gal, man 
8 gal, fuc 
N, 8 gal, a glu 
N, 8 gal, 8 glu 
N, 8 gal, man 
N, 8 gal, fuc 
8 gal, a glu, 8 glu 
8 gal, a glu, man 
S gal, a glu, fuc 
a glu, 8 glu, man 
a glu, S glu, fuc 
a glu, 8 glu 
a glu, man 
8 glu, man 
B glu, fuc 
a glu, fuc 
fuc, man 
S gal, a glu, 8 glu, man, fuc -
8 gal, a glu, (3 glu, man 
B gal, a glu, 8 glu, fuc 
Abbreviations: N = neuraminidase 0.2%;0.1 unit of the following: 
gal = galactosidase, glu = glucosidase, man = 
mannosidase, fuc = fucosidase; CHO-ase = carbohy-
drases together. 
CHAPTER IV 
DISCUSSION 
Immunologic cross reactivity between human GBM and group A, type 
12 SCM have been observed in several laboratories (5, 6, 16, 19, 25, 
37). Cross reactivity between Swiss white mouse and antisera directed 
against human GBM and group A type 12 SCM have also been noted (5, 6, 
12). The nephritogenic antigen in both human GBM and SCM has been 
shown to be glycoproteins (19, 20). The reciprocal cross reactivity 
between human GBM and SCM has been postulated as a significant mechanism 
in the development of post streptococcal glomerulonephritis (3, 4, 5). 
Previously, our laboratory determined the immunologic reactivity 
of various anti-SCM and anti-GB~1 antisera. The cross reactive phenomena 
resides in at least 2 entities, the protein and the carbohydrate por-
tions of SCM and human GBM. This study has confirmed that anti-SC~1 and 
anti-GBr1 directed primarily against carbohydrate moieties show reduced 
reactivity or become totally non-reactive when carbohydrate is removed 
from human or mouse GBM. Conversely, antisera directed against primari-
ly protein epitopes gain in reactivity after the removal of carbohy-
drates from GBM. 
A mechanism has been proposed to explain this phenomenon (5). It 
was suggested that carbohydrate eiptopes mask protein antigenic deter-
minants. Thus an anti- 11 protein 11 antiserum would react to a greater 
degree after carbohydrases had removed masking elements. Similar 
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carbohydrate masking has been observed in virus and transformed cell 
lines (47). 
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This research has shown that both anti- 11 carbohydrate" and anti-
"protein" antisera will bind to human GBM. It appears that both may 
play a role in the mechanism of postreptococcal glomerulonephritis (4~ 
5). Since it has been observed that rabbits immunized with native GBM 
and S0\1 produce primarily an anti - 11 protei n" determinant response (4) 
and that hemorrhagic skin necrotic factor for guinea pigs resides only 
in the anti- 11 protein 11 antisera, {5, 6) it can be proposed that such anti-
11protein11 antisera play a greater role in the mechanism of the disease 
than do the anti- 11 carbohydrate 11 antisera. 
The masking effect was not seen when neonatal human kidneys were 
studied. Anti-SCM "carbohydrate .. antisera were notably non-reactive in 
human neonates, indicating little or no cross reactivity between SCH 
carbohydrate and neonatal GBM. It has previously been shown that both 
human and mouse neonatal GBM have reduced carbohydrate content. The 
failure of anti- 11 carbohydrate 11 antisera to react with neonatal tissue 
may be explained on the basis of the lack of reactive antigens (4, 6). 
This finding is of itself not totally surprising since adult tissue was 
the source of the original antigen used in the preparation of the anti-
. sera. 
When mouse GBM was reacted with anti-SCM and anti-GBt-1 11 protein 11 
antisera, a similar masking effect was observed. In both adult and 
neonatal mice, anti- 11 protein 11 antisera increased in immunofluorescence 
after carbohydrase treatment. 
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Anti-GBr1 "carbohydrate~~ antisera were found to be reactive less 
frequently in the mouse adult and not at all reactive in the neonate. 
A similar loss of fluorescence after carbohydra·se treatment was noted. 
Anti-SCM 11 Carbohydrate 11 antiserum failed to react with either adult or 
neonatal mouse. This suggests that antigens of SCM and human GBM that 
are cross reactive with mouse GBM are primarily protein in nature. It 
must also be noted that the mouse is a valid model for further SCM and 
GBM antigen studies. 
This research has also given additional evidence for the nature 6f 
cross-reactive antigens in 3 species of mice: Swiss white, C3H and 
C57Bl. It has been shown that there are antigenic differences in the 
3 species and that these differences were apparent in the in vivo study 
of anti-GBM and anti-SCM "protein" antiserum evaluation of neonatal 
litter mates. It can be proposed that additional antigenic changes 
occur after 25 days and that these changes account for the variation 
in reactivity observed. It should also be noted that the anti-"protein" 
antisera were determined to be most reactive with mouse GBM. 
This research has failed to demonstrate significant change in 
urine production or proteinuria after injection of adult mice with an 
anti-GBM "protein" antiserum, despite the presence of significant 
fluorescence. Little is known in regard to the time sequence between 
deposition of IgG in the GBM and the appearance of proteinuria in the 
urine. 
After human and mouse kidney sections were incubated with carbo-
hydrases, singly and in pairs, and evaluated with anti-SCM and anti-
GBM "protein" antisera, an increase in immunofluorescence was noted. 
58 
Generally, incubation with 3 or more carbohydrases increased the degree 
of fluorescence often to the same degree as those tissues incubated in 
all carbohydrases. The presence of neuraminidase also had a notable 
effect on the fluorescent reactivity of tissues evaluated with anti-SCM 
and anti-GBM .. protein .. antisera. 
Anti-SCr~ and anti-GBM .. carbohydrate" antisera sho'-'Jed a similar 
decrease in fluorescence after incubation with carbohydrases, singly 
and in combinations. As with the anti- 11protein 11 antisera, changes were 
noted in those tissues incubated with 3 or more enzymes or in combina-
tion with neuraminidase. 
The observation that treatment with neuraminidase produces marked 
changes in reactivity of the material is understandable in that sialic 
acid, the substrate of neuraminidase, is often a terminal carbohydrate 
in a glycoprotein. Neuraminidase has been found to cleave 4 types of 
linkages: 2-3, 2-4, 2-6, and 2-8 a-glycosidic linkages between the 
terminal N-acetylneuramic acid and mucopolysaccharide (46). It is 
possible that removal of this terminal carbohydrate allows the other 
carbohydrases to reach their substrates more easily. Additionally, 
since sialic acid has a high negative charge, it may also have some 
electrostatic repulsive effect on antibody molecules. The removal of 
the sialic acid may then allow the approach and reaction of the anti-
body with its antigenic site. 
A proposed mechanism for post streptococcal glomerulonephritis 
has been based on the observed cross reactivity of group A strepto-
coccal cell membrane and human glomerular basement membrane. This 
mechanism depends on the immunologic and possibly similar chemical 
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structure of the protein antigens (5, 6, 19, 20). 
It has been long recognized that post streptococcal glomerulo-
nephritis occurs predominantly in children. It has been proposed that 
adults are less susceptible because the reactive sites have become 
masked with carbohydrate units during the maturation process thus 
preventing the deposition of nephrotoxic antibodies. 
The sequence of events may be as follows, after a pharyngeal or 
pyodermic infection with group A 8-hemolytic streptococci of a nephri-
togenic type cross reacting anti-SC~1 antibodies can be formed. Such 
antibodies could react with GBM protein antigens similar in immuno-
genicity to SCM. Complement activation could lead to accumulation of 
polymorpholeucocytes and to activation of the coagulation sequence. 
It has been suggested that these cells can in turn release carbohydrases 
continuing the exposure of cross reactive antigens and the continuation 
of GBM damage leading to red cell casts and proteinuria noted in most 
severe forms of post streptococcal glomerulonephritis. Adults, as 
statistics indicate are less susceptible, presumably, because of the 
masking of their cross reactive sites thereby minimizing chances of 
the initial immunologic reaction and thus there would not be any subse-
quent PMN attraction. This phenomenon, in adqition to the proposed 
enhanced accumulation of protective antibody, may be the basis for the 
low incidence of post streptococcal sequela in adults. 
CHAPTER V 
SUMMARY 
Antigenic cross reactivity between mouse and human glomerular 
basement membranes and group A s-he~~lytic streptococcal cell membrane, 
type 12, was evaluated using the immunofluorescent techniques. Neo-
natal and carbohydrase treated adult GBM were found to be more reactive 
with anti-SCM and anti-GBM "protein" antisera. A lack of cross reacti-
vity between carbohydrate antigens of SCt1 and human and mouse GBM was 
confirmed. Combinations of enzymes were found to produce intermediate 
fluoresence between untreated and carbohydrase treated tissues. 
Antigenic differences in thehuman tissues studied were 
observed, while little antigenic differences were found within each 
of the three species of mice observed. Differences were found in the 
reactivities of adult mice of 3 species (Swiss white, C3H and C57Bl). 
In vivo immunofluorescent evaluation of mice gave similar degrees of 
fluorescence as the in vitro evaluation of untreated mouse kidney 
tissues. Three anti-"protein" antisera were found to react in the 
in vivo evaluation of neonatal litter mates. Two of these antisera 
were found to be positive on day 0 and to remain so through their 25th 
day of 1 ife. 
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